Joinstar Biomedical Technology Co., Ltd.

Founded in December 2010, Joinstar Biomedical Technology Co., Ltd. (hereinafter referred to as Joinstar) is a national high-tech enterprise specializing in the R&D, production, and marketing of in vitro diagnosis (IVD) products. In addition, it has been awarded various honors, including National Key "Little Giant" Enterprise in the First Batch, Zhejiang Provincial Hidden Champion Enterprise, Soonicorn, Key Pre-IPO Enterprise in Hangzhou, Model Collective in Hangzhou, Winner of the Second Prize of Zhejiang Provincial Science and Technology Progress Award, and Key Enterprise for Pandemic Prevention and Control in Zhejiang.

Since its establishment, Joinstar has been committed to providing medical diagnosis and human health services. Far-sighted as it is, Joinstar has kept pursuing the best, most outstanding, and most unique solutions by deploying the i-211 strategic layout from disease prevention and auxiliary diagnosis through chronic disease management and health management, that is, underpinned by three technical platforms of core biological raw materials, quick diagnosis, and liquid chip, Joinstar is expanding the medical insurance and non-medical insurance markets, with the former focusing on hierarchical medical institutions and tiered medical services at the grass-roots level, and the latter highlighting health management and industrial chain incubation. With the ultimate goal to protect human health, Joinstar forges ahead and makes every effort to develop itself into an innovative and philanthropic enterprise that respects society and the environment, makes its employees proud, and wins long-term trust from partners.